Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Brickell Biotech (BBI) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with BBI stock chart to see long term trends.

BBI stock compared to

BBI Income Statement

Revenue, Net:27000
Revenue Per Share:0
Research & Development Expense:4559000
Total Operating Expenses:7428000
Operating Income:-7401000
Net Income:-7365000
Earnings Per Share, Basic:0.18
Shares Outstanding, Basic Avg:24514157

BBI Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-4751000
Net Cash from Financing Activities:14715000
Property, Plant & Equipment Purchases:null
Net Cash from Investing Activities:-23000
Net Change in Cash & Equivalents:9941000

BBI Balance Sheet

Cash and Cash Equivalents:30115000
Total Current Assets:33530000
Property, Plant & Equipment, Net:30000
Total Assets:33634000
Accounts Payable:568000
Total Short-Term Liabilities:6353000
Total Liabilities:6499000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Sabby Management, LLC
721,887 sh
721,887 sh
NEW
$652
$652
Vanguard Group Inc
634,078 sh
281,200 sh
80%
$573
$220
Renaissance Technologies LLC
618,150 sh
133,156 sh
27%
$558
$73
Blackrock Inc.
44,431 sh
 
$40
Morgan Stanley
2,086 sh
-15 sh
-1%
$2
Bank Of America Corp /De/
305 sh
-1,359 sh
-82%
$0
-$2
Goldman Sachs Group Inc
0 sh
-74,277 sh
-100%
$0
-$74
Proequities, Inc.
0 sh
 
$0

Data imported from Brickell Biotech, Inc. SEC filings. Check original filings before making any investment decision.